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ABSTRACT
Genomic research and biobanking present several ethical, social and
cultural challenges, particularly when conducted in settings with
limited scientiﬁc research capacity. One of these challenges is
determining the model of consent that should support the
sharing of human biological samples and data in the context of
international collaborative research. In this paper, we report on
the views of key research stakeholders in Ghana on what should
count as good ethical practice when seeking consent for genomic
research and biobanking in Africa. This study was part of a multi-
country qualitative case study conducted in three African
countries: Ghana, Uganda and Zambia under the auspices of the
Human Heredity and Health in Africa initiative (H3Africa). Our
study suggests that while participants are willing to give consent
for their samples and associated data to be used for future
research purposes, they expect to receive feedback about the
progress of the research and about the kinds of research being
undertaken on their samples and data. These expectations need
to be anticipated and discussed during the consent process which
should be seen as part of an ongoing communication process
throughout the research process.
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Introduction
In recent years, the key ethical challenges in the review and conduct of genomic research
and biobanking in Africa have received considerable attention (de Vries et al., 2011; Mar-
shall et al., 2006; Nyika, 2009; Parker & Bull, 2009). One of the most important of these is
the question of which model of consent is most appropriate for decisions about future
reuse of human biological samples and associated data in the context of international col-
laborative research (Igbe & Adebamowo, 2012; Tindana et al., 2012; Traore et al., 2015;
Wendler & Emanuel, 2002). The challenges associated with obtaining valid consent in
human subjects research in general have been well documented in the literature
(Mandava, Pace, Campbell, Emanuel, & Grady, 2012; Marshall, 2008; Molyneux, Peshu,
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&Marsh, 2004) and there is evidence to suggest that while consent is widely acknowledged
as an important pillar for the ethical conduct of research with humans, applying the prin-
ciples and practice of informed consent, as stipulated in existing international and national
ethics guidelines, presents diﬃcult challenges for the conduct of genomic research and bio-
banking (de Vries et al., 2011; Grady et al., 2015; Wright, Koornhof, Adeyemo, & Tiﬃn,
2013).
A review of empirical studies on broad consent has suggested that there is a growing
acceptance of broad consent, i.e. consent obtained at the time of sample collection for
future research purposes, as a model for future research with human biological samples
(Tindana & de Vries, 2016). This is based on the challenges with seeking speciﬁc
consent where it is not possible to specify all future research uses in detail or where recon-
senting participants is very diﬃcult. There is also recognition that to be ethically accepta-
ble, broad consent should be supported by appropriate governance structures to increase
the utility of the samples and allow important scientiﬁc projects to be undertaken while
respecting the rights and protecting the interests of research participants and their com-
munities (Grady et al., 2015; Tindana & de Vries, 2016).
Questions, however, remain about how acceptable the concept of broad consent is and
what counts as best practice when seeking consent for novel scientiﬁc projects such as
genomics and biobanking in Africa. Two authors of this paper have previously suggested
that seeking broad consent for future uses of samples is a form of entrustment and that
certain conditions such as community engagement ought to be in place to complement
broad consent (Tindana, Molyneux, Bull, & Parker, 2017). The concept of dynamic
consent has also been proposed as a model of consent that uses information technology
(IT) to facilitate engagement with participants and sample donors and enable them to
consent to new research projects over a period of time (Kaye et al., 2015; Stein et al.,
2013). However, this technology-based model of consent could face challenges in resource
constrained settings, particularly in Africa.
We conducted a multi-country case study in Ghana, Uganda and Zambia under the
auspices of the Human Heredity and Health in Africa initiative (H3Africa) to explore
key stakeholders’ perspectives on good ethical practice for the review and conduct of geno-
mics and biobanking in Africa. This paper reports on the Ghana case study and is based on
an analysis of key stakeholders’ views on seeking consent for genomics and biobanking in
international collaborative genomic research.
Methods
The Ghana case study for this three-country study involved document reviews, obser-
vation of consent processes, focus group discussions, individual interviews and delibera-
tive workshops with key stakeholders. While indepth interviews and focus group
discussions are rather standard in qualitative research and hardly requires introduction,
deliberative workshops are more novel and have not often been used in this kind of
work. Drawing upon deliberative approaches to empirical ethics and deliberative democ-
racy (Abelson et al., 2003; Marsh et al., 2013; O’Doherty, Hawkins, & Burgess, 2012;
Parker, 2002), this method involves providing participants with the facts about a particular
issue including the various views and perspectives about the issue. Then, based on this,
participants are asked to reﬂect and identify the ethical issues and suggest possible
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solutions for addressing them. The goal is to arrive at a consensus on what should count as
good ethical practice. The long process of deliberation is what distinguishes this method
from traditional focus group discussions.
Study setting
The study was conducted in the Kassena-Nankana districts of northern Ghana which
hosts the Navrongo Health Research Centre (NHRC), a research institution that has
been involved in international research collaborations for over 30 years (Oduro et al.,
2012). The community members in these districts are familiar with genomic research.
Three major genomic studies have been conducted in the area in the past, namely the
MalariaGen project from 2005 to 2009 (MalariaGEN, 2008), a pathogen genomic research,
and a collaborative genomic study between the Wits Health Consortium and InDepth
Network focusing on cardiometabolic disease under the auspices of the Human Heredity
and Health in Africa (H3Africa) initiative (H3Africa Consortium, 2014; Ramsay et al.,
2016). Previous empirical ethics studies have focused on malaria genomic studies invol-
ving young children (Tindana et al., 2012; Tindana, Molyneux, & Bull, 2014) and explored
the perspectives of parents and other stakeholders. This study was conducted between
2015 and 2016 and focused on the genomics of non-communicable diseases involving
research participants between the ages of 40 and 60 years. We were also interested in
getting a better understanding of how the challenges with consent identiﬁed in previous
studies have evolved over the years. This research was approved by the Navrongo
Health Research Centre Institutional Review Board (no. NHRCIRB206), the Ghana
Health Service Ethical Review Committee (No.GHS-ERC-GM 07/02/16) and the
Oxford University research ethics committee (OxTREC Reference: 580–16). Written
informed consent was obtained from all the stakeholders interviewed.
Sampling and data collection
Three categories of stakeholders were purposively selected for interviews as outlined in
Table 1.
Stakeholder group 1 included implementers of research. We approached all the
genomic researchers, ﬁeldworkers, study coordinator and laboratory technicians involved
in the AWI-Gen study for interviews. Stakeholder group 2 were members of research
ethics committees who reviewed H3Africa research protocols in Ghana. An invitation
was extended to all the members of the committees through their administrators and a
Table 1. Sample of participants.
Stakeholder group Description Type of interview Number of interviews
Implementers of research Genomic researchers IDIs 2
Fieldworkers IDIs 1
Field coordinator IDIs 1
Laboratory staﬀ FGDs 1 (6 discussants)
Reviewers of research Members of research ethics
committees
Deliberative
workshops
2 (8 participants in each
workshop)
Research participants and
community members
AWI-Gen participants and those
who refused
IDIs and FGDs 17 IDIs
12 FGDs
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convenient date for the committees was agreed upon. Stakeholder group 3 included AWI-
Gen study participants and those who refused to take part in the genomic study. While the
selection of groups 1 and 2 was quite simple, the selection for the third group of partici-
pants was more complex.
The AWI-Gen project recruited 2000 individuals between ages 40 and 60 years from
four geographic zones of the Kassena-Nankana districts (North, South, East and West).
We randomly selected two of these zones (East and West) for the Ethics project. With
a list of participants obtained from the research team, ﬁfty (50) AWI-Gen participants
from each zone were selected and contacted individually in their homes for indepth inter-
views and focus group discussions. The project also had a record of community members
who had refused to take part in the genomic study. Ten (10) of these community members
were randomly selected and approached for interviews. Of these, three (3) refused to par-
ticipate in the Ethics project.
Data collection
Document review
The document review involved the collection and review of institutional and national
ethics guidelines and regulations governing health research in general with a focus on
the requirements for conducting genomic research and biobanking in Ghana. Themes
identiﬁed through this analysis were explored through indepth interviews with key stake-
holders (members of ethics committees, genomic researchers, ﬁeldworkers and research
participants) on what should count as good ethical practice.
Participant observation during the consent process
This study was conducted in relation to the third genomic study to be conducted in the
Kassena-Nankana districts in 2016, namely the H3Africa AWI-Gen project which
focused on cardiometabolic diseases (Ramsay et al., 2016). This project utilised a three-
stage consent process: an initial contact with potential participants at the community
level to inform them about the study and to invite interested and willing participants to
the recruitment centre for further discussions; group discussions with all potential partici-
pants reporting at the recruitment centre where the project is explained to them; and
ﬁnally one-on-one individual informed consent in a separate room where participants
make a decision to either participate in the research or decline. Those who consent thumb-
print or sign the consent forms.
In the ethics project reported here, the Ghana study team sought verbal consent from
the AWI-Gen study team and participants to observe the group consent sessions at the
recruitment centre. Given that the disclosure of information is one of the key elements
of informed consent, we sought to gain a better understanding of how information
about the genomic study was shared with the participants and the questions raised by par-
ticipants. Notes were taken on how the genomic concepts of the project were explained in
the local languages including the use of sample collection tubes to explain the amount of
blood to be obtained from the participants. Only two group discussions were observed and
no names or personal information of the participants were recorded.
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Indepth interviews, focus group discussions and deliberative workshops
A total of 126 people participated in this study; 21 individual interviews (2 researchers, 2
ﬁeldstaﬀ, 10 genomic research participants and 7 refusers), 14 focus group discussions
(involving an average of 6 people in each group) and 2 deliberative workshops with
members of 2 research ethics committees (involving 8 REC members in each group).
The topics discussed during these indepth interviews and group discussions focused on
general views on genomics research, understanding of the rationale for sample and data
sharing, views on broad consent and other models of consent and recommendations
for good ethical practice. The individual interviews lasted for an average of 45 min
while the FGDs were about an hour.
The deliberative workshops were conducted with members of two research ethics com-
mittees in Ghana. This involved a formal presentation on the ethical issues in genomic
research, the challenges with consent and the pros and cons of current proposed
consent models such as broad and dynamic consent. Following the presentation of
these materials, participants were asked to discuss selected issues and provide practical sol-
utions for the way forward. These discussions were recorded in minutes, which were used
to inform the formal analysis of the data obtained in these deliberative workshops. The
workshops followed on from the IDIs and FGDs and thus built on some of the themes
that emerged from these interviews.
Data management and analysis
All the interviews and focus group discussions were audio-recorded except one of the
deliberative workshops with the research ethics committees, where the members collec-
tively declined audio recording. Detailed notes were taken during this meeting and
formed part of the data analysis. All the focus group discussions and individual interviews
with the community members were conducted in the local languages (Kasem and
Nankani). These were translated into English during the transcription process by two
research assistants.
Data analysis was ongoing throughout the study, using thematic content analysis.
Guided by the objectives of the research, we developed a coding scheme to facilitate the
data analysis, aided by the qualitative analysis software, NVivo 10. We explored themes
around general understanding of genomics among the research participants, views on
the consent process used in the genomic research study and recommendations on how
these processes could be improved for future studies. We also paid particular attention
to new issues emerging from the data such as the importance of feedback of research results.
Results
The results of the document reviews will be reported in a seperate manuscript. This paper
focuses on the key overarching themes that emerged from the interviews and focus group
discussions. These include understanding and recall of the genomic study; the process of
disclosure of information, acceptability of broad consent for sample and data sharing; and
expectations on feedback of ﬁndings. This paper discusses these themes in turn with
extracts from the interviews used to support these ﬁndings.
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General understanding and recall of genomic research
Valid consent requires that potential participants understand the research and voluntarily
agree to participate or decline participation. To elicit views on what will count as good
ethical practice when seeking consent to genomics and biobanking, it was important to
explore stakeholders’ general knowledge about key concepts in genomics and biobanking
such as the rationale for sample and data sharing. The interviews with genomic research
participants were conducted 6 months after their participation in the H3Africa genomic
study and most were able to recall in detail each of the processes they were taken
through during the project. They gave descriptions of what they were told about the
project, the diﬀerent tests and measurements that were conducted on them, the
diﬀerent samples (blood and urine) they provided and so forth.
She said that,… . there has been an increase in diseases like stroke and those related to the
heart and therefore there was the need to conduct this study to ﬁnd some treatment to those
diseases. For this reason, they needed to take our blood samples to carry out some test so they
could study those diseases. (FGD with women)
Most participants also recalled that the project was a collaborative study involving
several countries including Ghana and that the samples and data would be sent to
South Africa for further analysis and shared with other scientists.
We were also told that some of the blood samples will be kept here [in Navrongo]and some
too will be sent abroad for testing but the results of the blood sent abroad will not be ready
now, it will take some time. (FGD with women, EAST)
Two local terms for genes emerged during the interviews: “nkurugu” in Nankani and
“Nyinyogo” for Kasem. These terms were used to describe inherited traits that are
passed on from one generation to another in the two local languages:
It is diﬃcult to explain what “nkurugu” is in our local language unlike in English or Akan, but
what I know is that it means what you have inherited from your parents and therefore take
after their bloodline and their likeness. It has to do with inheritance from generations in your
family. That is my understanding. (FGD with male genomic research participant)
Some participants in the focus group discussions explained that there are certain dis-
eases that run through families which suggested that they have some general understand-
ing of the concept of heredity and health, which is important in the conduct of genomic
research. It is noteworthy that some participants mentioned diseases that are not familial
inherited diseases or what would normally be referred to as “genetic diseases” as demon-
strated in the quote below:
All these diseases they’ve mentioned; epilepsy, leprosy and tuberculosis are diseases that can
be found in the blood and can be transferred or inherited through a family line. As long as
you belong to a family that has any of these diseases, the likelihood of a member from that
same family getting such a disease high. It doesn’t matter the generation of such a family,
someone will inherit it. (FGD with female genomic research participants)
As noted in our observation of the consent process described earlier, many of the commu-
nity members we interviewed did not raise questions about other aspects of the genomic
study such as data and sample sharing.
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Addressing local sensitivities to blood sampling
Local communities’ sensitivities to blood sampling have been well documented in the lit-
erature (Beidelman, 1963; Fairhead, Leach, & Small, 2006; Molyneux & Geissler, 2008;
Tindana et al., 2014) and previous studies conducted in Kassena-Nankana districts have
also highlighted community members’ apprehensions about the collection of blood
samples for research purposes (Tindana et al., 2012, 2014). Not surprisingly, these were
also of concern to research participants in the present study. According to the ﬁeld staﬀ
we interviewed, residents in the local community often question the rationale for collect-
ing blood from an individual for research purposes and the implications of such pro-
cedures on the health of that individual. Group discussions with the ﬁeld staﬀ also
suggested that even when participants have agreed to take part in the study and report
to the recruitment centre, they become agitated during the blood sampling process.
You know we used these tubes, about ﬁve tubes for the blood. And in the local language they
will refer to these tubes as “Kolma” in Nankam or “Salma” in Kasem which is similar to a beer
bottle… , so when you go [to the community] to invite them it’s not always easy but when
they come, they see that the tubes are small. When you want to interpret the “tube” to them in
the local language, you have to use the word “bottle” and bottle means “the big bottle” but the
local people too will take it to mean “beer bottle”. (Fieldworker, male)
These claims by ﬁeld staﬀ about community views on the collection of tubes of blood
were conﬁrmed by our interviews with the research participants themselves, as illustrated
in the quote below:
They made us lie down in a room and they run some checks on us with a machine […]. But
before that, we were given some forms. We later on went into a room where blood was taken.
3 bottles were taken from some people, others 4 and others also had 5 bottles taken. At that
point, some of us got upset because we felt that if they wanted to carry out any test; they
would need just 1 bottle to do that, not 3, 4 or 5 bottles… (FGD with genomic research
participant)
Field staﬀ who handled the blood sampling process during the recruitment also gave
narratives about some cultural beliefs and implications of collecting blood from commu-
nity members who are strongly rooted in a more traditional way of life, which includes
beliefs in the power of amulets. For instance, one laboratory staﬀ member related the fol-
lowing story:
We had one man who willingly gave out his hand [for blood sampling], then when we pre-
pared the hand and wanted to go into the vein he asked me if I have excused him? Then I said
oh I did that, maybe you didn’t hear. Then he said no, I didn’t. Well I can go ahead; I tried
even the second time and I failed, then he said [it is ]because I did not inform him or excuse
him in a manner that he will understand. So I was wondering how I was supposed to put it,
then, he himself told me that I should say “gafara” I want to pick blood from him. And when I
did, I was able to draw the blood. So, after drawing the blood he explained to me how it
should be done. He was wearing a whole lot of [traditional] things on his body! (FGD
with research staﬀ)
The gafara referred to in the above narrative means “excuse me” and the oldman was
essentially telling the research staﬀ the importance of expressing this traditional way of
seeking permission before drawing blood samples. Some of the laboratory staﬀ we inter-
viewed admitted that they did not speak the local language of the research participants and
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thus when issues were raised at the point of sample collection, they were unable to respond
appropriately due to this barrier in communication. Surprisingly, none of the research par-
ticipants we interviewed mentioned barrier in communication as a challenge in the
consent process.
Views on seeking consent for biobanks
In seeking the views of the study participants on the concept and practice of broad
consent, we needed to explain what the concept is, why it has been proposed as a
model for genomics and biobanking and the other alternative models of consent such
as blanket consent, multilayered, tiered consent and dynamic consent. There was
general acceptance of the broad consent model by most of the stakeholders we interviewed
including among the research staﬀ and genomic research participants.
It wouldn’t be an issue since you people are the ones doing the work and know what is best. If
such samples are useful, you can go ahead to use them for our beneﬁt as well as yours. (IDI
with female genomic research participant 02)
However, other respondents, particularly the RECmembers and researchers were of the
view that eﬀorts should be made to keep participants and community members updated
on the status of research conducted on these stored samples, as a way of sustaining a trust
relationship between the research team and the local communities and allowing some
control over these samples.
the participants should know exactly what the samples are likely to be used for in the near
future. So, if it’s broad at least, let the participants know the kind of research or the kind of
studies that the samples will be used for in future. So maybe if its malaria research, maybe
sickle cell research or something else just be clear about that but I think it’s somehow
similar to the second type, multi-layered consent. (group discussions with RECs 01)
Discussions on broad consent also raised issues about the feasibility of using stored
samples for future studies. Some participants could not comprehend that it is possible
for samples to be stored for many years and be used for research that can provide any
meaningful information.
In my opinion, I would rather prefer they come back and take new blood samples to work
with rather than use the old samples. To me, such samples could go bad and no matter
how it is preserved, it might not be as potent as the fresh blood, such stored samples are
expired. Laughing! (FGD with male genomic research participant)
Most REC members were, however, skeptical about the use of broad consent and rec-
ommended that this model should be reviewed with some caution. They suggested that
each protocol should be reviewed based on its own merit and the use of broad consent
should be justiﬁed. Thus broad consent should be the exception and not the rule.
If care is not taken, it will turn out that every form of consent being sought will be broad
consent and that is not good, it should be considered based on the type of research work
to be carried out. (group discussion with RECs 02)
These responses suggest that despite the growing recommendations in international
guidelines on broad consent as a model for genomics and biobanks, participants expect
8 P. TINDANA ET AL.
the community – and themselves as individual participants – to receive feedback about the
progress of the research and about the kinds of research being undertaken on their samples
and data.
For me it is good to let us know; “when two people set up a trap for a prey, it is best for the
same two to inspect the trap to see whether there is a catch or not”. If such reserved sample is
still potent, it’s good to let us know before it is used for further studies. On the other hand, if
the samples are spoilt, you still will need to inform us so we can provide new samples. (FGD
with male genomic research participants)
The research ethics committees and research team were of the view that there is an
urgent need for clear national and institutional ethical standards to guide the review
and conduct of genomics and biobanking in Ghana. A national document should
clearly stipulate that all genomic studies should be reviewed by a national or institutional
ethics committee and for local research institutions to have control over the samples col-
lected and exported for analysis.
The issue of researchers collecting blood samples and asking to store it for future use is
becoming too common. There must be some regulation on this. (Discussant; group discus-
sion with REC02)
there should be clear guidelines as to the limit of the use of the samples. How am I going to use
the samples? Towhat extend can I use the samples? And if am using these samples, to whom do
I go to? Towhomdo I go?Do I go to the national ethics bodies? Should I go back to the research
participants? All these should be clearly spelt out in guidelines. (IDI with researcher 01)
Interviews with the researchers, ﬁeld staﬀ and members of the research ethics commit-
tees suggested that there is an important role for RECs in any governance framework for
genomics and biobanking. They suggested that decisions about future uses of samples and
data should involve the RECs that originally reviewed the proposal:
I have no problem with the sharing of the samples but it should be done in an ethically sound
manner. And it should be done such that, whichever ethics committee that is going to grant
approval for the sample to be used should always have a link with the mother group so that
you are updated as to the extent to which your samples are being used. So if you have some
objectives to make, you can, otherwise it will look as if you can just pick someone’s sample,
take it somewhere and then manipulate it in whatever way because this is genes we are talking
about so you can always manipulate genes anyhow. So if you don’t have a hand in it and it
reaches a point whereby the sample can be used by anybody elsewhere, you can’t tell when
things will go wrong. (DI with researcher 3, NHRC)
Surprisingly, most of the AWI-Gen research participants were not familiar with the work
of the research ethics committees and thus could not provide recommendations on how
RECs could be involved in governance issues:
I am aware that for every work that is to go on well, there must be a committee to oversee that
work. What I do not know is the details of the committee’s work. (IDI with male participant,
EAST)
Taking feedback of research results seriously
An important theme that emerged from interviews with all the stakeholders was the
importance of feedback of research results to participants and communities. During the
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course of the H3Africa AWI-Gen project, the results of the baseline assessments such as
the height, weight and blood pressure were given to the participants. Some respondents in
our ethics study expressed gratitude that they were referred to the hospital for treatment
when their test results were outside the normal values. There was, however, an expectation
that further tests conducted on the samples would be shared with participants, although
they did not explicitly indicate whether the results they expected should include individual
genetic results and/or general research results:
Yes, they told us they were going to take some of the blood samples abroad and investigate
further about other illnesses we may have. So, we are still waiting for feedback from them.
(IDI with female genomic research participant 03)
As suggested in the above extracts, the expectations for feedback from these participants
are based not only on the desire for knowledge on their health status but also a fulﬁlment
of an assurance given by the research team. There were clear indications from these inter-
views that the ﬁeld staﬀ seeking consent had given some assurances that eﬀorts would be
made to provide feedback at the end of the project and this had raised participants’
expectations.
The issue of feedback of results was such a strong theme throughout the interviews that it
emerged as one of the main reasons why some members of the local community refused to
participate in the genomic study. According to the ﬁeldworkers who conducted the consent
process for the project, there is some dissatisfaction among some sections of the community
about the lack of feedback from previous studies involving sample collection. These views
were conﬁrmed in our interviews with “refusers” in the various communities:
they ever came and took blood samples for a similar purpose and did not come back to tell us
anything about the blood they took nor the screening they did. I told them I was no longer
interested and for that matter I was not prepared to go this time around. Whether the ﬁrst
time they took the blood and sold or they discovered some diseases, they never came back.
Under this circumstance, why would I be interested in participating again? I need the blood
in my veins to be able to work. (IDI with a refuser 05)
I know that the quantity [of blood], is small but the fact that the ﬁrst group did not come back
to tell us what they used our blood for or whether they discovered any diseases, has discour-
aged me. (IDI with refuser 02)
This lack of feedback from previous studies has discouraged some members of the com-
munity from participating in research and getting involved in any activities related to
research. These responses highlight the importance of feedback to research participants
and the need for researchers to take this seriously in the research process. Feedback was
also seen as a way of closing the study so that participants do not assume that the
study is still ongoing. In addition, the feedback process was seen as a way to empower
members of the community with knowledge about their health status.
Researchers and laboratory personnel were of the view that while feedback of results is
important, care needs to be taken on the nature of the feedback and how that information
is handled. In reference to the population structure component of the project, where
family trios (mother, father, child) were recruited, they suggested that issues about pater-
nity were raised which suggested that such information is regarded as sensitive and best
kept private:
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I remember in the population structure aspect, some of them asked because we were taking
trios, father, mother and child. So, some of them asked questions like, you know these have to
do with paternity issues whether or not you’re going to ﬁnd out that this person is my child,
and all those things and actually that has been one of the main issues. (FGD with research
staﬀ)
You know there are some diseases or some conditions that are peculiar to certain families and
they are such that they keep it secret. So, if you’re going to work on people’s blood, they begin
to think that you’ll discover some of those secret conditions that are only known to the family
and they don’t want people out there to get to know. (FGD with research staﬀ)
It is worth stating that during the initial contact with the genomic research participants
to take part in this ethics project, many of them brought out the consent forms they signed
for the genomics project and asked if the ethics project team had come to disseminate the
results from the genomic study.
Discussion
Seeking valid consent is one of the key ethical challenges in the review and conduct of
genomic research and biobanking globally. Recent revisions of international guidelines
such as Council for International Organization of Medical Sciences (CIOMS) recommend
broad informed consent as a model for research involving future uses of samples and
associated data (CIOMS, 2016). However, there is still ongoing debate about its acceptabil-
ity in Africa. The results of this study conﬁrm that the challenges with seeking informed
consent for genomic studies persist, even in communities that have been exposed to these
types of studies for over a decade.
While it was clear that the genomic research participants we interviewed in this study
had a general understanding of the various procedures involved in the genomic research
project and expressed their willingness to participate, they also expressed some concerns
about sample collection. This is consistent with previous empirical studies conducted in
this study setting (Tindana et al., 2012, 2014) and other research settings in Africa (Beidel-
man, 1963; Fairhead et al., 2006; Molyneux & Geissler, 2008). The fact that these concerns
persist even after engagement processes within the community suggest that research pro-
jects need to anticipate these local cultural sensitivities around blood sample collection and
address themmore pro-actively during the community engagement and informed consent
process. Researchers should use innovative ways of explaining the quantity of blood col-
lected for research process. This could involve, taking the blood collecting tubes to the
community and demonstrating how the actual sampling process is conducted to demystify
the process.
The study has also highlighted the need for consent to be seen as a communicative
process throughout the research process, including at the point of sample collection.
While this is recommended for all types of studies, there is very limited data on how
often researchers engage with participants beyond the initial consent process including
the sample collection stage. Given the complexities in genomic research and the com-
munication barriers highlighted by the laboratory staﬀ, there is the need to strengthen
the cultural competence and language skills of research staﬀ who interact directly with
research participants at various stages of the research process including those involved
in sample collection.
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Feedback of research ﬁndings emerged as an important theme both in our observation
of the consent process and the interviews and focus group discussions conducted with the
various stakeholders. There is a strong expectation from research participants that the
results of the genomic study including the implication of these results, would be shared
with them.
There are several factors that could be contributing to these community expectations
for feedback. The H3Africa genomics project recruited healthy adults, who had donated
blood samples for studies on cardiometabolic disease. This appears to have raised expec-
tations from the participants on knowing the results of the various tests conducted on the
samples and the implications on their health. There was therefore some evidence of a
“diagnostic misconception” where participants assumed that the collection of samples
for research is for diagnostic purposes, as reported in other H3Africa studies in South
Africa (Kutschenko, 2012; Masiye, Mayosi, & de Vries, 2017). Second, in the process of
seeking consent, ﬁeld staﬀ had made assurances to participants that results would be
shared with them. These promises were also made during the group consent processes
we observed. The latter highlights the need for staﬀ seeking consent to be cautious
about making promises that may not be fulﬁlled during the research process. While
there is extensive literature on feedback of individual genetic research ﬁndings including
how to handle incidental ﬁndings (Dixon-Woods, Tarrant, Jackson, Jones, & Kenyon,
2011; Fernandez, Kodish, & Weijer, 2003; Knoppers, Deschênes, Zawati, & Tassé, 2013;
MacNeil & Fernandez, 2006), discussions on these issues have only evolved recently
within the H3Africa Consortium in Africa (H3Africa Feedback of Findings Policy ).
The literature suggests that in the context of genomics and biobanking, there are
diﬀerent kinds of research results that can be returned to research participants. Knoppers
et al have classiﬁed these ﬁndings as follows: Baseline assessments which include measure-
ments such as blood pressure, lung function, bone density, height, weight, fat, and others
are taken at baseline or at any subsequent assessment; Individual genetic ﬁndings are those
discovered during research, which concerns an individual participant, and have potential
health or reproductive impact; Incidental ﬁndings are unforeseen ﬁndings concerning a
research participant that has potential health or reproductive importance. These are dis-
covered in the course of the research but are outside its objectives. General research results
refer to aggregate results drawn from the analysis of data and samples of a group of
research participants (Fernandez et al., 2003; Knoppers et al., 2013). The H3Africa guide-
line for the return of individual genetic ﬁnding recommends that return of individual
genetic ﬁndings should proceed with caution and should follow a careful consideration
of key principles. This includes assessing “whether the particular ﬁnding holds value for
the individual” and ensuring that “patients are appropriately informed of the implications
of the ﬁndings” (H3Africa Feedback of Findings Policy ). Further studies should be
encouraged to clarify which of these types of ﬁndings are considered valuable to research
participants and communities and how such ﬁndings should be communicated.
In the context of biobanks, empirical studies have suggested that despite the growing
acceptance of broad consent for genomics and biobanking, there is also an expectation
from research participants and sample donors for some feedback on the range of projects
that draw on their samples and data. Increasingly, authors have argued that researchers
have an ethical obligation to share research results to participants based on the principles
of respect, beneﬁcence and reciprocity (Dixon-Woods et al., 2011; Fernandez et al., 2003;
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Knoppers et al., 2013; MacNeil & Fernandez, 2006). Communicating research results does
not only demonstrate respect to participants but is also a way of acknowledging their
important contribution to science. Feedback is also about sharing knowledge which
could help participants and their communities live healthier lifestyles which could contrib-
ute to positive health outcomes. For example, Kerasidou has proposed that communicat-
ing aggregate ﬁndings from genomic studies should be perceived as “sharing knowledge”
and not just “returning results”. She argues that the dissemination of “aggregate ﬁndings as
sharing of knowledge not only describes the exercise more accurately but can also help
mitigate some of the risks involved with returning non-individual aggregate results” (Ker-
asidou, 2015). A key challenge to sharing such aggregate knowledge is ﬁnding the appro-
priate methods and how the views of communities ought to be incorporated into policies
guiding decisions on when, how and what to feedback to research participants and com-
munities participating in genomic studies. Further exploratory studies will be helpful to
unpack these issues and provide recommendations on how research results could be
shared with individuals, groups and communities.
It is interesting that although there is support for the use of broad consent for
sample and data sharing, participants in our study described a desire for information
on the use of these samples, the results of the tests conducted and the implications on
their health. These responses including those from members of the research ethics
committees suggest that participants should be regularly updated about the status of
their samples.
Dynamic consent has been proposed as a model of consent that uses information tech-
nology (IT) to enable participants to consent to new research projects over a period of time
(Kaye et al., 2015; Stein & Terry, 2013; Steinsbekk, Myskja, & Solberg, 2013). Whilst this
has a number of limitations as an approach to consent, and the technology required for
this model will present challenges in these rural African settings, the idea of a dynamic
platform for ongoing communication between participants and researchers about research
being undertaken and uses of samples, is appealing for its potential to increase conﬁdence
and trust in the research and researchers. We suggest that future research should explore
possibilities for combining technology-based approaches to include more traditional
methods of communication such as community durbars [gatherings] and meetings to
facilitate feedback of research results to participants and ongoing communication with
research participants and communities.
Conclusion
Seeking consent for genomic research and biobanking remains one of the key ethical
challenges in international collaborative genomic research. Our study suggests that
what would count as good ethical practice is an approach in which consent is seen
as part of an ongoing communication process throughout the research process;
where there is regular feedback of study ﬁndings to the participants; and where par-
ticipants have some control over what will happen to their samples and data. Partici-
pants’ high expectation for feedback is likely to aﬀect the conduct of future genomics
studies in these communities if these expectations are not met. We encourage further
empirical ethics studies to identify best practices for sharing genomic research results
to research participants and communities.
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